Feature

Is kratom the answer to the opioid crisis?


 


Dr. Goldberger, Dr. Levounis, Dr. Grundmann, and Dr. Holcomb had no disclosures. Dr. Galbis-Reig disclosed in his study that he is the owner of stock in GW Pharmaceuticals and Cortex Pharmaceuticals, Pfizer bonds, and has spousal ownership of stock in AbbVie, Abbott Pharma, and Hospira. Dr. Swogger and other authors of the systematic review reported serving as consultants for the American Kratom Association, as well as sponsors of other kratom products.

Pages

Recommended Reading

Opioid use higher in adults with health conditions
MDedge Rheumatology
Helpful schedules ease task of tapering opioids
MDedge Rheumatology
What can happen if you fail to check the PDMP?
MDedge Rheumatology
Psoriasis patients face higher risk of alcohol-related death – but lower suicide risk
MDedge Rheumatology
White House opioid panel calls for more addiction specialists
MDedge Rheumatology
CMS to enlist Medicare Part D plans to combat opioid abuse
MDedge Rheumatology
New buprenorphine formulation approved for medication-assisted treatment
MDedge Rheumatology
Health care gets little attention in State of the Union address
MDedge Rheumatology
Opioid prescriptions got shorter in 2017
MDedge Rheumatology
MDedge Daily News: Stem cells may reverse premature menopause
MDedge Rheumatology